News & Events
Portuguese Politicians experience MS symptoms
National Multiple Sclerosis Day marked across Portugal
Neonatal vitamin D and the risk of MS
Further evidence shows the role of vitamin D in MS risk, especially during pregnancy
Recruitment complete for new progressive MS drug trial
250 people with progressive MS are taking part in the SPRINT-MS trial for ibudilast
Research highlights of 2016
Professor Alan Thompson highlights some of 2016’s research discoveries in MS
Tawasol – December 2016 issue
Issue 17: 11 organisations from the Arab region share their news
400 young people gather in Rome to learn about MS
‘Young people beyond MS’
No link between NR1H3 p.Arg415Gln and multiple sclerosis risk
A new study fails to replicate the role of a gene in developing primary progressive MS
Rituximab in multiple sclerosis
A retrospective study of rituximab use in MS shows evidence for its safety and effectiveness
Social cognition in multiple sclerosis
People with MS display increased deficiencies in social cognition
Geographical latitude and the onset of MS
People from countries with higher latitudes are found to have an earlier onset of MS
Further evidence for effectiveness of alemtuzumab
Study shows alemtuzumab can improve pre-existing disability in relapsing-remitting MS
MSIF in Latin America
Earlier this month our CEO Peer Baneke and Head of Capacity Building Zoe Burr travelled to Buenos…